CLINICAL AND SUBCLINICAL CHARACTERISTICS OF PATIENTS WITH DE NOVO DISTANT METASTATIC NASOPHARYNGEAL CARCINOMA AT VIETNAM NATIONAL CANCER HOSPITAL

Đăng Nguyễn Văn, Hoa Lê Thị

Main Article Content

Abstract

Purpose: To describe some clinical and subclinical characteristics of de novo distant metastatic nasopharyngeal carcinoma. Materials and Methods: A cross-sectional descriptive study was conducted on 72 patients with de novo distant metastatic nasopharyngeal carcinoma at Vietnam National Cancer Hospital from January 2017 to December 2024. Results: The mean age was 53.6 ± 10.6 years, with a male-to-female ratio of 3.5:1. The most common reason for hospital admission was cervical lymphadenopathy (86.1%). The average time from symptom onset to diagnosis was 4.24 months. T3–T4 tumors accounted for 52.7%, and N2–N3 lymph node involvement for 76.4%. Bone was the most frequent site of distant metastasis (54.2%), followed by the lungs (33.3%), distant lymph nodes (26.4%), and liver (20.8%). Most patients had metastasis on a single organ (69.4%). Common radiological features of distant metastases included sclerotic bone lesions, multiple small pulmonary nodules, and hypodense liver lesions with poor contrast enhancement. Conclusion: De novo distant metastatic nasopharyngeal carcinoma is commonly observed in middle-aged men, often presenting with nonspecific clinical symptoms that lead to delayed detection. Cervical lymphadenopathy is the most common reason for hospital admission. Bone is the most frequent site of distant metastasis. Radiology plays a critical role in lesion detection and evaluation. 

Article Details

References

1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2024;74(3):229-263. doi:10.3322/ caac.21834
2. Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. The Lancet. 2019;394(10192): 64-80. doi:10.1016/S0140-6736(19) 30956-0
3. National Comprehensive Cancer Network Head and Neck Cancers, version 2.2025. Accessed April 12, 2025. https://www.nccn. org/professionals/physician_gls/pdf/head-and-neck.pdf
4. You R, Liu YP, Huang PY, et al. Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial. JAMA Oncology. 2020;6(9):1345-1352. doi:10. 1001/jamaoncol.2020.1808
5. Zou X, You R, Liu H, et al. Establishment and validation of M1 stage subdivisions for de novo metastatic nasopharyngeal carcinoma to better predict prognosis and guide treatment. Eur J Cancer. 2017;77: 117-126. doi:10.1016/j.ejca. 2017.02.029
6. Qu W, Li S, Zhang M, Qiao Q. Pattern and prognosis of distant metastases in nasopharyngeal carcinoma: A large‐population retrospective analysis. Cancer Med. 2020;9(17):6147-6158. doi:10.1002/cam4.3301
7. Ai QY, Hu CW, Bhatia KS, et al. Nasopharyngeal carcinoma: relationship between invasion of the prevertebral space and distant metastases. Eur Arch Otorhinolaryngol. 2018; 275(2):497-505. doi:10.1007/s00405-017-4825-z
8. Shen C, Lu JJ, Gu Y, Zhu G, Hu C, He S. Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated by definitive radiation therapy. Laryngoscope 2008;118:1206–1210
9. Xu Y, Huang T, Fan L, Jin W, Chen X, Chen J. Patterns and prognostic value of lymph node metastasis on distant metastasis and survival in nasopharyngeal carcinoma: a surveillance, epidemiology, and end results study, 2006–2015. J Oncol. 2019;2019:4094395
10. Zhao CL, Qian GQ, Chen XY, Chen C. Retrograde analysis of clinical characteristics of bone metastasis in 1,031 cases of preliminarily diagnosed nasopharyngeal carcinoma. Asian Pac J Cancer Prev. 2014;15(8):3785-3788. doi:10.7314/ apjcp.2014.15.8.3785